Genexol inj. applicable to stomach cancer as additional indication

Samyang Corporation said that Genexol (paclitaxel) inj., a chemotherapy that is given as a treatment for some types of cancer such as ovarian, breast and non-small cell lung cancer, was approved from the Korea Food and Drug Administration as an additional treatment of stomach cancer on February 23, based on the results of Phase II clinical trial in Korean patients with stomach cancer, which wer...